139 related articles for article (PubMed ID: 5168761)
21. Effect of unilateral nephrectomy on the development of kidney tumor in rats treated with N-nitrosodimethylamine.
Ito N; Hiasa Y; Tamai A; Yoshida K
Gan; 1969 Jun; 60(3):319-27. PubMed ID: 5346015
[No Abstract] [Full Text] [Related]
22. [Effects of 2,5-di-O-acetyl-D-glucaro-(1,4) (6,3)-dilactone (SLA) on experimental bladder tumor induced by N-butyl-N-(4-hydroxybutyl) nitrosamine].
Ito N; Hiasa Y; Kamamoto Y; Makiura S; Okajima E
Gan No Rinsho; 1970 Sep; 16(10):995-1001. PubMed ID: 5528978
[No Abstract] [Full Text] [Related]
23. Species variations in the metabolism of N-butyl-N-(4-hydroxybutyl) nitrosamine and related compounds in relation to urinary bladder carcinogenesis.
Suzuki E; Anjo T; Aoki J; Okada M
Gan; 1983 Feb; 74(1):60-8. PubMed ID: 6840438
[TBL] [Abstract][Full Text] [Related]
24. Scanning and transmission electron microscopy of changes in the urinary bladder in rats treated with N-butyl-N-(4-hydroxybutyl)nitrosoamine.
Arai M; Kani T; Sugihara S; Matsumura K; Miyata Y; Shinohara Y; Ito N
Gan; 1974 Dec; 65(6):529-40. PubMed ID: 4465155
[No Abstract] [Full Text] [Related]
25. Pathology of tumours in laboratory animals. Tumours of the rat. Tumours of the kidney, renal pelvis and ureter.
Hard GC
IARC Sci Publ; 1990; (99):301-44. PubMed ID: 2093652
[No Abstract] [Full Text] [Related]
26. Metabolic fate of N-butyl-N-(4-hydroxybutyl) nitrosamine and N, N-dibutylnitrosamine in the guinea pig, with reference to their carcinogenic effects on the urinary bladder.
Suzuki E; Aoki J; Okada M
Gan; 1981 Aug; 72(4):547-51. PubMed ID: 7308666
[TBL] [Abstract][Full Text] [Related]
27. Metabolic fate and carcinogenicity of N-(omega-hydroxyalkyl) N-(4-hydroxybutyl) nitrosamines analogs of N-butyl-N-(4-hydroxy-butyl) nitrosamine, in the rat.
Suzuki E; Takeda Y; Mochizuki M; Hashimoto Y; Okada M
Gan; 1981 Aug; 72(4):539-46. PubMed ID: 7308665
[TBL] [Abstract][Full Text] [Related]
28. Effect of phenacetin and caffeine on the urinary bladder of rats treated with N-butyl-N-(4-hydroxybutyl)nitrosamine.
Nakanishi K; Fukushima S; Shibata M; Shirai T; Ogiso T; Ito N
Gan; 1978 Jun; 69(3):395-400. PubMed ID: 669140
[TBL] [Abstract][Full Text] [Related]
29. Response at fifteen weeks of the big brown bat (Eptesicus fuscus) to intraperitoneal injections of N-2-acetylaminofluorene.
Heldt LV; Rowe NH; Spain JD
Cancer Res; 1974 Oct; 34(10):2807-9. PubMed ID: 4472289
[No Abstract] [Full Text] [Related]
30. Metabolic fate of N,N-dibutylnitrosamine in the rat.
Suzuki E; Okada M
Gan; 1980 Dec; 71(6):863-70. PubMed ID: 7274631
[TBL] [Abstract][Full Text] [Related]
31. Development of an experimental model for studying bladder carcinogen metabolism using the isolated rat urinary bladder.
Airoldi L; Bonfanti M; Magagnotti C; Fanelli R
Cancer Res; 1987 Jul; 47(14):3697-700. PubMed ID: 3594434
[TBL] [Abstract][Full Text] [Related]
32. [Effect of cis-diamminedichloroplatinum (II) (CDDP) on bladder cancer on rats induced by N-butyl-N-(4-hydroxybutyl) nitrosamine (BBN)].
Miyakawa M; Yoshida O
Gan To Kagaku Ryoho; 1982 Feb; 9(2):258-62. PubMed ID: 6820893
[TBL] [Abstract][Full Text] [Related]
33. Summation effect of N-butyl-n-(4-hydroxybutyl)nitrosamine, N-(4-(5-nitro-2-furyl)-2-thiazoly)formamide, N-2-fluoroenylacetamide, and 3,3'-dichlorobenzidine on urinary bladder carcinogenesis in rats.
Tatematsu M; Miyata Y; Mizutani M; Hananouchi M; Hirose M
Gan; 1977 Apr; 68(2):193-202. PubMed ID: 892293
[TBL] [Abstract][Full Text] [Related]
34. Relationship of urinary N-butyl-N-(3-carboxypropyl)nitrosamine to susceptibility of animals to bladder carcinogenesis by N-butyl-N-(4-hydroxybutyl)nitrosamine.
Suzuki E; Mochizuki M; Okada M
Gan; 1983 Jun; 74(3):360-4. PubMed ID: 6884694
[TBL] [Abstract][Full Text] [Related]
35. Mutagenicity of N-butyl-N-(4-hydroxybutyl)nitrosamine, a bladder carcinogen, and related compounds.
Nagao M; Suzuki E; Yasuo K; Yahagi T; Seino Y
Cancer Res; 1977 Feb; 37(2):399-407. PubMed ID: 318920
[TBL] [Abstract][Full Text] [Related]
36. Metabolism of butyl(4-hydroxybutyl)nitrosoamine in rats.
Okada M; Suzuki E
Gan; 1972 Jun; 63(3):391-2. PubMed ID: 5072839
[No Abstract] [Full Text] [Related]
37. Consideration for treatment of upper urinary tract tumors with topical therapy.
Huffman JL; Morse MJ; Herr HW; Whitmore WF
Urology; 1985 Oct; 26(4 Suppl):47-50. PubMed ID: 4049628
[TBL] [Abstract][Full Text] [Related]
38. Primary carcinoma in situ of renal pelvis and ureter.
Murphy WM; von Buedingen RP; Poley RW
Cancer; 1974 Oct; 34(4):1126-30. PubMed ID: 4417875
[No Abstract] [Full Text] [Related]
39. [Multiple localization of uroepithelial tumors].
Nilsson S; Angervall L; Bengtsson U; Gottfries A; Johansson S; Wahlqvist L
Nord Med; 1971 Oct; 86(40):1156-7. PubMed ID: 5167205
[No Abstract] [Full Text] [Related]
40. Damage and repair of DNA in urinary bladder epithelium of rats treated with N-butyl-N-(4-hydroxybutyl) nitrosamine.
Tsuda H; Miyata Y; Hagiwara A; Hasegawa R; Shirai T; Ito N
Gan; 1977 Dec; 68(6):781-3. PubMed ID: 598647
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
